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Abstract
Background: In a dog with joint pain, it is important to determine whether it has suppurative joint disease,
characterized by exudation of neutrophils in the synovial fluid, or not, as this affects choice of diagnostic tests
and treatments. The aim of this study was to evaluate whether measurement of serum C-reactive protein (CRP)
concentration could be used to discriminate between dogs with suppurative arthritis and osteoarthritis (OA).
Furthermore, the concentrations of serum and synovial fluid interleukin (IL) 6 concentrations were measured in
dogs with joint disease and in healthy dogs, and were correlated to serum CRP concentrations.
Methods: Dogs with joint pain were enrolled prospectively and were classified to have suppurative arthritis or
OA based on synovial fluid analysis and radiographic/arthroscopic findings. Healthy Beagles were enrolled
as a comparative group. CRP and IL-6 concentrations were measured with canine-specific immunoassays.
The performance of CRP concentration in discriminating between dogs with suppurative arthritis and OA
was evaluated using a previously established clinical decision limit for CRP (20 mg/l), and by receiver
operator characteristic (ROC) curve and logistic regression analysis. Comparisons of CRP and IL-6 concentrations
between groups were performed using t-tests, and correlations by Spearman rank correlation coefficients.
Results: Samples were obtained from 31 dogs with suppurative arthritis, 34 dogs with OA, and 17 healthy dogs.
Sixty-two out of 65 dogs with joint disease were correctly classified using the clinical decision limit for CRP.
Evaluation of ROC curve and regression analysis indicated that serum CRP concentrations could discriminate
between suppurative arthritis and OA. Dogs with suppurative arthritis had higher serum CRP and serum and
synovial fluid IL-6 concentrations compared to dogs with OA (p < 0.001). Dogs with OA had higher synovial
fluid IL-6 concentrations (p < 0.001), but not higher serum CRP (p = 0.29) or serum IL-6 (p = 0.07) concentrations,
compared to healthy dogs. There was a positive correlation between synovial fluid IL-6 and serum CRP concentrations
(rs = 0.733, p < 0.001), and between serum IL-6 and serum CRP concentrations (rs = 0.729, p < 0.001).
Conclusion: CRP concentration was found to discriminate well between dogs with suppurative arthritis and OA.
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Background
Osteoarthritis (OA), septic arthritis and immune-
mediated arthritis are important causes of joint pain in
dogs. Osteoarthritis is a slowly progressive condition
with deterioration of articular cartilage, osteophyte
formation, and changes in periarticular tissues [1]. Al-
though historically considered to be a non-inflammatory
disease, there is evidence that local inflammation plays a
part in the pathogenesis of OA [2], and increased activity
of pro-inflammatory cytokines have been found in syn-
ovial fluid (SF) of affected dogs [3, 4]. However, neutro-
phil numbers in the SF are not increased in dogs with
OA [5]. This is in contrast to dogs with septic and
immune-mediated arthritis, which both are character-
ized by suppurative arthritis with exudation of neutro-
phils in the synovial fluid [6–8].
When a dog is admitted to veterinary care because of
joint pain, it is important to rapidly determine whether
suppurative arthritis is likely or not, as this affects the
choice of further diagnostic testing and treatments. In a
dog with suppurative arthritis, SF analysis should
promptly be performed and treatment with antibiotics
or glucocorticoids is often needed [7, 9]. This is in con-
trast to OA, which is usually a less acute condition not
requiring arthrocentesis for SF analysis. Although find-
ings at physical examination often differ in the two
conditions, with signs of systemic inflammation fre-
quently being present in dogs with suppurative arthritis
but not in OA [1, 7, 8], the clinical picture is not always
clear [8, 10, 11]. A circulating biomarker that could dis-
criminate between suppurative arthritis and OA is thus
wanted. In cases of suppurative arthritis, it is further
necessary to establish an etiologic diagnosis as treatment
strategies are dependent on the cause of inflammation
[6, 7]. The differentiation of septic and immune-
mediated arthritis can be challenging because results
from SF analysis are similar, and specific findings such
as bacteria, ragocytes and lupus erythematosus cells are
often absent [5]. Moreover, the result from SF bacterial
culture is not rapidly available, and false negative culture
results are common [6, 12]. Hence, there is need for
alternative biomarkers with the potential to discriminate
septic from immune-mediated arthritis.
C-reactive protein (CRP) is an acute phase protein
produced in the liver in response to increased con-
centrations of interleukin (IL) 6 during inflammation
[13, 14]. Measurement of circulating concentrations
of CRP in dogs has been shown to be clinically useful
for diagnosing and monitoring systemic inflammatory
diseases [15, 16]. C-reactive protein has the advantages of
being an objective, quantitative marker of inflammation
[17] that is not biased by treatment with non-steroidal
anti-inflammatory drugs (NSAID) [18–20] or glucocorti-
coids [21]. This is in contrast to other markers of systemic
inflammation such as fever and evaluation of the leuko-
gram [21, 22]. Because serum CRP concentrations have
been reported to be substantially elevated in suppurative
arthritis [23, 24], but not in OA [25, 26], our hypothesis
was that this marker should help differentiate be-
tween these two conditions. The aim of this study
was to investigate whether measurement of serum
CRP concentration could discriminate between dogs
with suppurative arthritis and dogs with OA, and be-
tween dogs with septic suppurative and immune-
mediated suppurative arthritis. An additional aim was
to measure and compare concentrations of serum
CRP, serum IL-6, and SF IL-6 in dogs with suppurative
arthritis, OA, and in healthy dogs, and to investigate the
correlation between IL-6 and CRP concentrations. The
current study, comprising dogs with various degrees of
joint inflammation, constituted a suitable setting for gain-
ing additional knowledge about IL-6 and CRP concentra-




Client-owned dogs were enrolled to the study prospect-
ively from the University Animal Hospital, Swedish
University of Agricultural Sciences (SLU), Uppsala, or
Evidensia Södra Djursjukhuset, Stockholm, from January
1st 2012 to December 31st 2013.
Inclusion criterion was at least one painful joint as
determined by a veterinarian at physical examination.
Furthermore, it was required that the dog should have
arthrocentesis, arthroscopy or arthrotomy performed for
diagnostic or therapeutic purposes, and that one of the
authors (AH or JB) were attending during the procedure.
Exclusion criteria were pregnancy and glucocorticoid
treatment within four weeks prior to sampling. The vet-
erinary surgeon in charge was responsible for the man-
agement of the dog, which was not affected by
participation in the study. Medical records were studied
for identifying number of painful joints, presence of
other disease, treatments, and for follow-up during a
period of at least 2 weeks after sampling. Blood samples
were collected from the distal cephalic vein in EDTA
tubes and tubes without anti-coagulant1. Samples were
centrifuged after 30 min (5 min, 3000 G) and sera imme-
diately transferred to cryo-tubes2 and frozen at −80 °C,
or placed in liquid nitrogen until transferred to −80 °C.
Synovial fluid samples were aseptically collected by
arthrocentesis from 1–4 painful joints of each dog, prior
to any other interventions. The number of joints
sampled was determined by the veterinary surgeon in
charge. For cytokine analysis, one aliquot of SF was
centrifuged (5 min, 450 G) within 15 min and the super-
natant transferred to cryotubes and immediately stored
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at −80 °C, or placed in liquid nitrogen until transferred
to −80 °C. The remaining SF was used for nucleated cell
count (NCC), cytological examination, and bacterial
culture.
Eighteen purpose bred Beagle dogs, euthanized for
reasons other than participation in the present study,
were sampled at AstraZeneca R&D, Södertälje, and SLU.
Inclusion criteria for the control dogs were physical
examination without abnormal findings, no history of
medical treatment during the past two months, and that
the caretaker reported the dog to be healthy. Blood sam-
ples were collected from the jugular or distal cephalic
vein immediately prior to the dog being euthanized.
Synovial fluid samples were obtained while the dog was
under general anaesthesia, or within 5 min after euthan-
asia. Dogs with macroscopic joint lesions at post-
mortem inspection, or abnormalities on laboratory tests
results from blood and SF, were excluded. Samples from
the healthy dogs were handled similarly as described
above for the samples from cases. Maximal storage time
for all serum and SF samples was 2 years.
Analyses
Hematology, biochemistry and serology
A routine biochemistry profile was performed on an au-
tomated analyser3 in all of the dogs. The complete blood
cell count was assessed with an automated hematology
analyser4,5 within 6 h after collection, including manual
white blood cell (WBC) differential count. Results from
hematology and biochemistry analyses were compared
to locally established reference intervals for adult dogs.
Sera were analysed for the presence of antibodies against
Borrelia burgdorferi and Anaplasma phagocytophilum
with an indirect immunofluorescent-antibody assay at
the National Veterinary Institute, Uppsala, Sweden [27].
Synovial fluid analyses
Microscopic examination of SF including a nucleated
cell differential count was performed by a clinical path-
ologist (AH), who was blinded for history and clinical
findings at the time of examination. The SF nucleated
cell count (NCC) was assessed to be normal if ≤3 cells
per high-power field (100 x oil-immersion objective)
were found [5], with ≤5 % neutrophils. The presence of
mild, moderate or marked increased NCC on cytological
examination was subjectively assessed, as well as
erythrocyte numbers. The smears were screened for the
presence of microorganisms, ragocytes, and lupus
erythematosus cells [5]. When SF was available from
multiple joints from the same dog, each joint was evalu-
ated separately. Pathological bleeding was diagnosed if
macrophages containing erythrocytes and/or hemoglobin
breakdown pigment were found [5]. Iatrogenic bleeding
was defined as presence of moderately to marked numbers
of erythrocytes, without signs of pathological bleeding.
When SF volume was sufficient, nucleated cells were
counted using a hemocytometer (BÜrker chamber) after
treatment with 0.5 mg/ml hyaluronidase6 at 37 °C for
30 min. Bacterial culture was performed by adding
>1 ml of SF to aerobic medium blood culture con-
tainers7, that were cultured at 37 °C for maximum
7 days or until growth at the Section of Bacteriology,
National Veterinary Institute, Uppsala, Sweden. In
cases where the SF volume was not sufficient for cul-
ture in blood culture containers, SF was instead
transferred to a sterile cotton swab8 that was placed
in enrichment media prior to culture on horse blood
and bromcresole lactose purple agar plates.
Analysis of serum C-reactive protein and serum and
synovial fluid IL-6
Serum CRP concentration was determined with a previ-
ously validated canine-specific CRP assay9 with a meas-
urement range of 6.8-300 mg/l [28], on a fully automated,
open-system clinical chemistry/immunoassay analyserc.
Samples were analysed in duplicate in random order in a
single run. Samples with serum CRP concentrations
<6.8 mg/l, which was the limit of quantification (LOQ) of
the CRP assay, were immediately re-analyzed in duplicate
with a validated automated high-sensitivity CRP test10
with a LOQ of 0.5 mg/l [29]. Measurement of IL-6 was
performed with a canine-specific electrochemiluminescent
multiplex immunoassay with a measurement range of 2.4-
10 000 pg/ml11. Six 96 well plates were used in the study
and samples were analyzed according to the manufac-
turer’s instruction, with the exception that the SF samples
were diluted 1:2 with diluent provided from the manufac-
turer prior to analysis. Two control samples based on
pooled sera from dogs, with mean IL-6 concentration of
17 pg/ml and 50 pg/ml, were analyzed in duplicate on
each plate. The intra- and inter-assay coefficients of vari-
ation (CV) were 40.2 and 19.7 % for the low control, and
14.4 and 12.9 % for the high control. Two synovial fluid
samples of low and high viscosity, respectively, were
spiked with calibrator material to two different con-
centrations each, and observed recoveries after spiking
were 79-102 %. Hyaluronidase treatment of SF sam-
ples was tested but did not improve performance
(data not shown), and was therefore not used for the
study samples. Study samples were analyzed in dupli-
cate in random order, with the exception that serum
and SF samples were analyzed on separate plates.
Results were excluded if the CV of the duplicate
measurements was >30 %, which was subjectively
determined to be the maximal acceptable imprecision.
Results were also excluded if the sample had signs of
iatrogenic bleeding at cytological examination.
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Classification of disease status
Suppurative arthritis
Dogs were classified as having suppurative arthritis if
the SF NCC was ≥5000 cells/μl with ≥30 % neutro-
phils, without significant signs of pathological bleed-
ing. If an exact cell count was not available, a
moderately to markedly increased cell count on cyto-
logical examination was required for classification as
suppurative arthritis. Dogs with suppurative arthritis
were sub-classified in the following groups: septic
arthritis, immune-mediated arthritis, and unclassified
cases. Dogs with significant growth of bacteria on SF
bacterial culture, and/or intracellular bacteria detected
in neutrophils in SF cytology samples, were assigned
to the septic arthritis group. To be classified as a case
of immune-mediated arthritis, dogs should have nega-
tive bacterial culture, no bacteria on SF cytological
examination, show clinical improvement within 3 days
without being treated with antibiotics and/or repeated
joint lavage, and no diagnosis of septic arthritis within
2 weeks after inclusion in the study. Furthermore, the
attending clinician should have stated immune-
mediated arthritis as the most likely diagnosis in the
medical record. Dogs that did not fulfil criteria for
septic or immune-mediated arthritis were defined as
unclassified cases.
Osteoarthritis
Dogs were classified to have OA if the SF NCC count
was ≤3000/μl with ≤10 % neutrophils, without significant
signs of pathological bleeding. If an exact synovial fluid
cell count was not available, the cell count should be
low or mildly increased on cytological examination. It
was further required that the dog had arthroscopic and/
or radiographic evidence of OA described in the medical
record.
Dogs that did not fit into the suppurative arthritis or
OA group (SF NCC of >3000 but <5000/μl and/or neu-
trophil numbers >10 % but <30 %), were reported
separately.
Statistical analyses
A statistical software program was used for statistical
analyses12. Prior to analysis, CRP and IL-6 data were
transformed to the base 2-logarithmic scale (log2) be-
cause of non-normal distributions. Analyte concentra-
tions < LOQ were assigned a value of 0.5 x LOQ for the
statistical analyses.
Serum C-reactive protein as a discriminative test
Multiple logistic regression analysis adjusted for po-
tential confounders was performed to assess the asso-
ciation between log2CRP and outcome, defined as
suppurative arthritis/OA. The explanatory variables in
the initial model were log2CRP concentration, sex,
age, body weight and NSAID treatment. Backward
stepwise elimination of explanatory variables was used
to reduce the model, followed by forward inclusion,
until all included variables had a p-value <0.05. Ex-
planatory variables, whose inclusion changed the beta
coefficient of log2CRP by >20 %, were considered
possible confounders, and were retained in the model.
The goodness of fit was tested with the Hosmer and
Lemeshow test. The diagnostic performance of serum
CRP for discriminating between suppurative arthritis
and OA was assessed by receiver operating character-
istic (ROC) curve analysis. Serum CRP was defined as
an efficient marker if the lower limit of the 95 %
confidence interval of the area under the ROC curve
was >0.8. The discriminatory capacity of serum CRP
was further evaluated using a decision limit for CRP
of 20 mg/l, which was previously established as the
clinical decision limit for diagnosing systemic inflam-
mation at the University Animal Hospital, SLU. The
decision limit was determined by performing ROC
curve analysis of CRP data from dogs with and with-
out known systemic inflammatory disease (data not
shown), similarly to what has been previously
described [16]. In the current study, correct classifica-
tion was defined as CRP concentration ≥20 mg/l in a
dog with suppurative arthritis, and CRP concentration
<20 mg/l in a dog with OA. Comparison of log2CRP
concentrations in dogs with septic and immune-
mediated suppurative arthritis, and in dogs with and
without concurrent disease within the suppurative
arthritis group, was performed with Student’s t-test.
Statistical significance was defined as p <0.05.
Serum C-reactive protein and serum and synovial fluid
IL-6 concentrations in dogs with suppurative arthritis,
osteoarthritis, and in healthy dogs
Descriptive statistics were presented as median and
interquartile range (Q1-Q3) for serum CRP and
serum and SF IL-6 concentrations. When SF IL-6 re-
sults were available from several joints from the same
dog, the mean SF IL-6 concentration was used for
calculations. Pairwise comparisons were performed
between groups of dogs with suppurative arthritis and
OA, and between healthy dogs and dogs with OA
respectively, using the unequal variance t-test for
log2CRP and log2IL-6 concentrations. Additional com-
parisons between groups were performed with the
Mann–Whitney U test for continuous variables, and
Fisher’s exact test for categorical data. The p-value
threshold for statistical significance was adjusted for
multiple testing using a Bonferroni correction for 14
tests (0.0036).
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Correlation between serum and synovial fluid IL-6 and
serum C-reactive protein concentrations
The correlations between serum and SF IL-6 concentra-
tions and serum CRP concentrations were evaluated by
calculating Spearman rank correlation coefficients.
When SF IL-6 results were available from several joints
from the same dog, the mean SF IL-6 concentration was




Seventy-six dogs of 29 different breeds were sampled in
the study, whereof 11 dogs were excluded (Fig. 1). The
remaining dogs were classified as suppurative arthritis
(n = 31) or OA (n = 34) cases (Table 1). For dogs that
had multiple joints sampled (n = 8), the same classifica-
tion was obtained regardless of which joint that was
evaluated.
In dogs with suppurative arthritis the NCC was mod-
erately to markedly increased on cytological examin-
ation, and the percentage of neutrophils was 65–96 %.
Cell counts performed in a hemacytometer (n = 22) were
between 6000–272 000/μl. Intracellular bacteria were
present on cytological examination in the sample of one
dog that also had a positive bacterial culture. Ragocytes
or lupus erythematosus cells were not detected in any of
the dogs. Bacterial cultures were performed in blood
culture containers in 13 samples, and from sterile cotton
swabs in 18 samples. Bacterial culture results were
positive in 4 dogs that were subsequently classified as
septic arthritis cases, and negative in the other dogs.
Immune-mediated arthritis was diagnosed in 8 dogs.
The remaining 19 dogs with suppurative arthritis were
treated with antibiotics but infection was not confirmed,
and therefore they were allocated to the group of unclas-
sified suppurative arthritis cases. Concurrent disease was
recorded in 13/31 dogs with suppurative arthritis, most
commonly gastrointestinal disease (n = 7). Laboratory
test abnormalities included non-regenerative anemia
(n = 6) neutrophilia (n = 12), left shift with band neu-
trophils >0.5 × 109/L (n = 13), lymphopenia (n = 15),
thrombocytopenia (n = 5), hypoalbuminemia (n = 13),
and increased alanine aminotransferase (n = 2) and
alkaline phosphatase (n = 2) activity. Nineteen dogs
had neutrophilia and/or left shift, whereas neutrophil
numbers and morphology were assessed to be normal
in the remaining 12 dogs. In one dog, inclusions con-
sistent with Anaplasma phagocytophilum were present
in blood neutrophils.
Dogs with OA had osteochondritis dissecans (n = 10),
cranial cruciate ligament injury (n = 12), unspecified car-
tilage defect (n = 7), fragmented coronoid process (n = 2)
and/or synovitis (n = 10). Synovial fluid NCC were 150–
1700 /μl with 0–10 % neutrophils, and there were no
abnormal morphological findings on cytological examin-
ation. Bacterial cultures were performed on cotton swabs
(n = 26) and in blood culture containers (n = 8), and were
negative in all dogs. No dog had concurrent disease re-
ported. Abnormalities on hematology and biochemistry
Fig. 1 Flow diagram of dogs with joint pain eligible for inclusion in the study. The diagnostic cut-off value for C-reactive protein (CRP) was
20 mg/l. Dogs were classified to have suppurative (supp) arthritis or osteoarthritis (OA) based on synovial fluid analysis (reference test);
for classification as OA, signs of OA on radiographs/arthroscopy was further required. Dogs with inconclusive test results were excluded.
1Pathological bleeding (n = 3) and non-diagnostic sample due to severe iatrogenic bleeding in synovial fluid sample (n = 2). 2No OA was
diagnosed on radiographs/arthroscopy (n = 2)
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testing included non-regenerative anemia (n = 5), neutro-
penia (n = 5), lymphopenia (n = 6) and hypoalbuminemia
(n = 8).
Antibodies against Anaplasma phagocytophilum,
Borrelia burgdorferi, or both, in a titre ≥80, were present
in 16/31 (52 %) dogs with suppurative arthritis and in
13/34 (38 %) dogs with OA; there was no significant
difference between the groups (p = 0.22).
Of the 18 dogs sampled as a comparative group, one
was excluded because of moderately increased ALAT
activity. Synovial fluid NCC in the remaining dogs were
160-810/μl, and no neutrophils were present on cyto-
logical examination.
Serum C-reactive protein as a discriminative test
In the logistic regression analysis with suppurative
arthritis/OA as outcome, the final model included
log2CRP (p = 0.03, OR 7.37) and sex (p = 0.12, OR 0.005)
as explanatory variables. The interpretation of OR for
log2CRP was that for a doubling of serum CRP concen-
tration, the odds of having suppurative arthritis in-
creased by a factor of 7.37. The area under the ROC
curve (95 % CI) was 0.99 (0.97-1.00). Based on ROC
curve analysis, the optimal decision limit for serum CRP
for discriminating between dogs with suppurative arth-
ritis and OA was 3.5 mg/l which was lower than the
locally established clinical decision limit, 20 mg/l. Using
the latter decision limit, two dogs in the suppurative
arthritis group with serum CRP concentrations of 6.0
and 3.9 mg/l were misclassified, as well as one dog in
the OA group with serum CRP concentration of 68 mg/l
(Fig. 1).
In dogs with septic suppurative arthritis (n = 4), the
median (range) serum CRP concentration was 81.5
(6.0-189) mg/l. The corresponding serum CRP con-
centrations in dogs with immune-mediated suppura-
tive arthritis (n = 8) was 118.0 (31–229) mg/l. Serum
CRP concentrations did not differ significantly be-
tween dogs with septic and immune-mediated sup-
purative arthritis (p = 0.46). There was no significant
difference in CRP concentration between dogs with
and without concurrent disease within the suppurative
arthritis group (p = 0.25).
Serum C-reactive protein and serum and synovial fluid
IL-6 concentrations in dogs with suppurative arthritis,
osteoarthritis, and in healthy dogs
Results from serum CRP measurements were available
from all dogs (n = 82). Interleukin-6 results were ex-
cluded from 17 serum and 11 SF samples, because the
CV of duplicate measurement was >30 %. Synovial fluid
IL-6 results were further excluded because of mild iatro-
genic blood contamination (n = 9). Dogs with suppura-
tive arthritis had increased serum CRP and serum and
SF IL-6 concentrations compared to dogs with OA
(Table 1). Dogs with OA had higher SF IL-6 concentra-
tions compared to healthy dogs, but there was no
difference between these two groups for serum IL-6 or
serum CRP (Table 1).
Correlation between serum and synovial fluid IL-6 and
serum C-reactive protein concentrations
There was a positive correlation between SF IL-6 and
serum CRP concentrations (rs = 0.733, p < 0.001), and
between serum IL-6 and serum CRP concentrations
(rs = 0.729, p < 0.001).
Discussion
The results from the current study showed that serum
CRP concentrations discriminated well between dogs
with suppurative arthritis and OA, with 62 out of 65
dogs (95 %) being correctly classified using a pre-
existing clinical decision limit for CRP. It has been
argued that a complete physical examination is usually
Table 1 Characterisation of dogs with osteoarthritis (OA), suppurative arthritis and healthy dogs
Parameter Median (IQR) P values
Osteoarthritis (n = 34) Suppurative arthritis
(n = 31)
Healthy (n = 17) Suppurative arthritis
vs OA
Healthy vs OA
Age (years) 2.7 (0.9-6.2) 4.2 (1.6-7.5) 1.8 (1.2-2.7) 0.19 0.33
Weight (kg) 32 (24–39) 28 (19–33) 14 (13–15) 0.11 <0.001
Serum CRP (mg/l) 0.73 (<0.50-2.45) 107 (43–145) 1.26 (0.62-2.32) <0.001 0.29
Serum IL-6a (pg/ml) 15.0 (10.2-26.5) 101 (47.7-243) 9.2 (8.0-11.4) <0.001 0.07
Synovial fluid IL-6b (pg/ml) 131 (21.5-450) 19 800 (4030- > 20 000) <2.4 (<2.4-3.9) <0.001 <0.001
Sex (male/female) 17/17 18/13 12/5 0.62 0.23
NSAID treatment (treatment/no treatment) 22/12 5/26 0/17 <0.001 <0.001
Serum C-reactive protein (CRP), serum interleukin (IL) 6 and synovial fluid IL-6 concentrations in dogs with osteoarthritis (OA), suppurative arthritis, and in healthy
dogs. Data is presented as median and interquartile range (IQR). Pairwise comparisons were performed between groups of dogs with OA and suppurative arthritis,
and between dogs with OA and healthy dogs. NSAID; non-steroidal anti-inflammatory drug
aSerum IL-6 results available from dogs with OA (n = 29), suppurative arthritis (n = 29), and healthy dogs (n = 7)
bSynovial fluid IL-6 results available from dogs with OA (n = 19), suppurative arthritis (n = 29), and from healthy dogs (n = 14)
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sufficient to adequately distinguish a dog with suppura-
tive arthritis from a dog with OA [15], but clinical signs
may be unspecific [8, 10, 11] and physical examination is
subjective in contrast to CRP, which is an objective
marker and thus less biased by level of clinical expertise.
The logistic regression model confirmed that increased
serum CRP concentrations were associated with a diag-
nosis of suppurative arthritis, compared to a diagnosis of
OA. Although sex remained as an explanatory variable
in the final model, we do not consider this to be of clin-
ical importance. Concurrent disease was not included as
an explanatory variable in the logistic regression model,
because all dogs with concurrent disease belonged to the
suppurative arthrithis group which would yield inad-
equate estimations. Instead, it was tested whether there
was a difference in CRP concentration in dogs with and
without concurrent disease within the suppurative arth-
ritis group. No such difference was found, and it was
concluded that the increased CRP concentration found
in dogs with suppurative arthritis was not due to pres-
ence of concurrent disease only.
There were two dogs in this study that had suppura-
tive arthritis based on SF examination, but yet low
serum CRP concentrations. This is not optimal, consid-
ering that suppurative arthritis should be promptly
treated [9] and that a false negative CRP result may
delay correct diagnosis if used as sole means of differen-
tiation. Both dogs lacked other clinical and laboratory
signs indicative of systemic inflammation (data not
shown), and it is possible that they had purely local joint
inflammation that did not elicit a systemic inflammatory
response.
A definitive diagnosis of septic or immune-mediated
arthritis was not possible to establish in all dogs, and
one reason for this was that many dogs with suppurative
arthritis received antibiotics despite negative bacterial
culture. Frequent antibiotic treatment has previously
been reported in dogs with immune-mediated suppura-
tive polyarthritis [11], which can be explained by the
difficulty in excluding infection in these patients.
Furthermore, underdiagnosis of septic arthritis in the
current study was possible considering that the more
sensitive method of bacterial cultures in blood culture
containers was not possible to perform in many cases
because of insufficient SF volumes [12]. Due to the low
number of animals with confirmed septic or immune-
mediated suppurative arthritis, the power of detecting an
existing difference in serum CRP concentration between
groups was low. However, considering the marked over-
lap in serum CRP concentrations in dogs with septic and
immune-mediated arthritis, it is unlikely that serum
CRP would be an efficient discriminatory test for these
two conditions. This is in line with the results of previ-
ous studies, in which serum CRP concentrations did not
differ between dogs with septic and non-septic inflam-
matory disease [23, 30, 31]. Although specific situations
may exist where serum CRP indeed could be helpful for
predicting presence of bacterial infection, as suggested
in dogs with respiratory disease [32], this is not generally
applicable.
Dogs with suppurative arthritis had increased serum
CRP and serum IL-6 concentrations compared to dogs
with OA, in agreement with what has been previously
described [15]. Synovial fluid IL-6 concentrations were
markedly increased in the suppurative arthritis group
compared to the OA group, which is in accordance with
the higher SF IL-6 activity earlier found in dogs with
rheumatoid suppurative arthritis compared to dogs with
OA [33]. However, in another study no difference in SF
IL-6 mRNA expression was detected when comparing
dogs with immune-mediated arthritis and OA [34].
Different methodologies used for measuring IL-6 could
possibly explain the diverging results in different studies.
Dogs with OA were compared to healthy dogs in order
to investigate if there was indication of local inflamma-
tion in joints affected by OA, as has been previously de-
scribed [4, 35]. The finding of increased SF IL-6
concentrations in dogs with OA compared to healthy
dogs, without increased serum CRP concentrations, sup-
ported that a local inflammation without significant sys-
temic effects was present. However, results from the
comparisons between healthy dogs and dogs with OA in
the current study need to be interpreted with caution
considering that the comparative group was not repre-
sentative of all dogs with OA. Factors such as breed and
age may affect serum CRP concentrations [36, 37], and
it is desirable to control for these possible confounders
when investigating CRP concentrations in the low range.
This was not possible in the current study because all
healthy dogs were Beagle dogs of similar age. The fre-
quency of NSAID treatment was also significantly differ-
ent between groups and because NSAID treatment may
influence IL-6 concentrations [38, 39], secondary effects
on CRP concentration could possibly occur. However,
treatment with NSAID did not significantly affect serum
CRP concentrations in three previous studies [18–20],
and it was therefore considered less likely that NSAID
treatment biased CRP results in the current study.
There was a positive correlation between IL-6 and
CRP concentrations which was expected, as IL-6 induces
hepatic CRP production [13, 14]. A full validation of the
IL-6 assay was not performed, which should be taken
into consideration when interpreting IL-6 results. Sug-
gested validation protocols for cytokine immunoassays
have been published [40], but such studies are demand-
ing to carry out and often lacking in veterinary medicine.
In the current study, only minor validation experiments
were performed (data not shown). However, the assay
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did detect the expected increased IL-6 concentrations in
dogs with suppurative arthritis. This indirectly implied
that it was a useful assay, not affected by the suspected
low analytical sensitivity that has been described for an-
other canine IL-6 immunoassay [41]. For diagnosing
suppurative arthritis in a clinical setting measurement of
IL-6 would not be the test of choice though, because
CRP was superior over IL-6 for discriminating between
dogs with OA and dogs with suppurative arthritis (data
not shown). Further advantages of the CRP assay include
that it is thoroughly validated, fully automated and more
cost effective compared to the IL-6 assay. C-reactive
protein also has the advantage of being more stable
during storage than IL-6 [42, 43]. It has previously been
reported that IL-6 is stable for approximately 2 years of
freeze storage [42], and for this reason the maximal stor-
age time in the current study was set to 2 years.
There was no difference in the number of dogs that
were seropositive for Anaplasma phagocytophilum and
Borrelia burgdorferi in dogs with suppurative arthritis
and OA. Although arthritis has been described in
dogs experimentally infected with Borrelia burgdorferi
[44, 45], and infection with Anaplasma phagocytophi-
lum has been suspected to cause immune-mediated
polyarthritis [22], it is often difficult to establish
causality between infection and arthritis in a clinical
setting which is why determination of a single anti-
body titre is considered to be of limited diagnostic
value. All healthy dogs in this study were seronega-
tive, which could be explained by the fact that they
were purpose bred research dogs and most of them
had not been exposed to ticks.
The clinical decision limit of serum CRP for diagnos-
ing systemic inflammation was set to 20 mg/l, which is
the limit used at the University Animal Hospital where
the study was conducted. This limit is comparable to a
previously recommended clinical decision limit for
serum CRP of 16.8 mg/l [16], established with a CRP
method giving similar results as the assay used in the
current study [28]. The optimal decision limit for serum
CRP based on ROC curve analysis in the present study
was 3.5 mg/l, but in a clinical setting such low decision
limit would likely give rise to an unacceptably large
number of false positive results. Further studies in an
independent setting would be needed to quantify the
specificity of such a low cut-off.
One important limitation of the current study was that
only dogs admitted for arthrocentesis or other invasive
procedure in the joint were eligible for inclusion. This
approach was chosen in order to avoid arthrocentesis
being performed for study purposes solely, but the
consequence was that the sampling population was not
representative of the patient population where CRP
testing would probably be most useful, i.e. in the early
diagnostic workup of dogs with joint pain of unknown
etiology. None of the dogs with OA was reported to
have concurrent disease, probably because dogs with
ongoing systemic inflammation would normally not be
referred to undergo a surgical procedure to diagnose or
treat OA. In a clinical setting it may be more likely to
encounter dogs suffering from both OA and concurrent
inflammatory disease, thus decreasing the efficacy of
serum CRP for discriminating between suppurative arth-
ritis and OA. Despite this, considering the pronounced
difference in CRP concentration between dogs with sup-
purative arthritis and OA, it is concluded that CRP is a
promising diagnostic marker in these patients. Future
studies should include prospective evaluation of dogs
with joint pain admitted to primary care clinics, in order
to evaluate if CRP measurements will improve patient
care in a cost-effective way.
Conclusions
Serum CRP concentration discriminated well between
dogs with suppurative arthritis and OA. There was no
difference in CRP concentration between dogs with sep-
tic and immune-mediated arthritis, but only few dogs
were included in this comparison and therefore the
power of detecting an existing difference in serum CRP
concentration between these two groups was low. Con-
centrations of serum CRP and serum and SF IL-6 were
higher in dogs with suppurative arthritis compared to
dogs with OA.
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